Shanghai Kehua Bio-Engineering Co Ltd Financial Flexibility Index
Shanghai Kehua Bio-Engineering Co Ltd financial flexibility index. Shanghai Kehua Bio-Engineering Co Ltd (002022) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥59.49 Million (operating CF CN¥28.25 Million minus capex CN¥31.24 Million) represents 0% of total liabilities (CN¥1.47 Billion). Explore Shanghai Kehua Bio-Engineering Co Ltd (002022) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shanghai Kehua Bio-Engineering Co Ltd (2002–2025)
Financial flexibility index of Shanghai Kehua Bio-Engineering Co Ltd from 2002 to 2025. Historical Financial Flexibility Index trend for Shanghai Kehua Bio-Engineering Co Ltd across 24 annual periods. Check 002022 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Shanghai Kehua Bio-Engineering Co Ltd Financial Flexibility Index by Year (2002–2025)
Shanghai Kehua Bio-Engineering Co Ltd financial flexibility index by year from 2002 to 2025. Year-by-year free cash flow to debt coverage for Shanghai Kehua Bio-Engineering Co Ltd. For the full cash flow conversion analysis, see Shanghai Kehua Bio-Engineering Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.11x | CN¥161.73 Million | CN¥22.44 Million | CN¥1.53 Billion | ▼ -35.3% |
| 2024 | 0.16x | CN¥204.70 Million | CN¥-50.12 Million | CN¥1.25 Billion | ▲ +306.8% |
| 2023 | -0.08x | CN¥-143.97 Million | CN¥-474.89 Million | CN¥1.82 Billion | ▼ -109.1% |
| 2022 | 0.87x | CN¥2.58 Billion | CN¥2.15 Billion | CN¥2.96 Billion | ▲ +22.8% |
| 2021 | 0.71x | CN¥1.30 Billion | CN¥1.08 Billion | CN¥1.82 Billion | ▼ -9.2% |
| 2020 | 0.78x | CN¥1.62 Billion | CN¥1.37 Billion | CN¥2.08 Billion | ▲ +103.8% |
| 2019 | 0.38x | CN¥389.08 Million | CN¥248.87 Million | CN¥1.01 Billion | ▲ +64.2% |
| 2018 | 0.23x | CN¥250.77 Million | CN¥126.79 Million | CN¥1.07 Billion | ▼ -37.0% |
| 2017 | 0.37x | CN¥235.83 Million | CN¥130.71 Million | CN¥636.48 Million | ▼ -59.3% |
| 2016 | 0.91x | CN¥384.50 Million | CN¥281.25 Million | CN¥422.47 Million | ▲ +1.6% |
| 2015 | 0.90x | CN¥309.92 Million | CN¥224.30 Million | CN¥345.97 Million | ▼ -58.7% |
| 2014 | 2.17x | CN¥350.30 Million | CN¥249.64 Million | CN¥161.39 Million | ▲ +4.5% |
| 2013 | 2.08x | CN¥336.60 Million | CN¥250.22 Million | CN¥162.08 Million | ▲ +44.2% |
| 2012 | 1.44x | CN¥286.72 Million | CN¥213.74 Million | CN¥199.05 Million | ▼ -13.1% |
| 2011 | 1.66x | CN¥291.45 Million | CN¥219.80 Million | CN¥175.89 Million | ▼ -7.8% |
| 2010 | 1.80x | CN¥279.74 Million | CN¥241.83 Million | CN¥155.58 Million | ▼ -7.7% |
| 2009 | 1.95x | CN¥259.21 Million | CN¥217.51 Million | CN¥133.03 Million | ▲ +17.3% |
| 2008 | 1.66x | CN¥155.36 Million | CN¥137.66 Million | CN¥93.56 Million | ▲ +60.2% |
| 2007 | 1.04x | CN¥130.74 Million | CN¥112.93 Million | CN¥126.16 Million | ▼ -20.2% |
| 2006 | 1.30x | CN¥112.29 Million | CN¥87.21 Million | CN¥86.46 Million | ▲ +12.8% |
| 2005 | 1.15x | CN¥87.89 Million | CN¥73.97 Million | CN¥76.32 Million | ▼ -21.7% |
| 2004 | 1.47x | CN¥93.43 Million | CN¥48.74 Million | CN¥63.51 Million | ▲ +26.9% |
| 2003 | 1.16x | CN¥95.42 Million | CN¥70.57 Million | CN¥82.31 Million | ▲ +48.2% |
| 2002 | 0.78x | CN¥62.04 Million | CN¥41.48 Million | CN¥79.29 Million | — |